Previously, two separate reports revealed that c-kit was significantly upregulated in 65% of ES patients and 38% of ES patients, respectively (Table 1; Ahmed et al., 2004; Do et al., 2007). This evidence concerns the gene KIT and epithelioid sarcoma.